NextGen Awards in Prostate Cancer

Prostate Cancer Canada (PCC) is offering a limited number of awards to provide a stipend for conducting prostate cancer research in three different categories: graduate studentship, post-doctoral research fellowship and clinical research fellowship.
The application is initiated an independent investigator who will act at the lead supervisor.
There are three types of award available:
  • Graduate Studentship: maximum amount of each award is $35,000/year for up to 2 years + up to $5,000 knowledge exchange stipend
  • Post-Doctoral Research Fellowship: maximum amount of each award is $50,000/year for up to 2 years + up to $5,000 knowledge exchange stipend
  • Clinical Research Fellowship: maximum amount of each award is $75,000/year for 1 year
Key Dates:

Registration Deadline: February 21, 2017 at 5:00 p.m. Eastern
Full Application Deadline: March 15, 2017 at 5:00 Eastern
Earliest Funding Start Date: July 1, 2017

Links to:
Online application:
https://pccgrants.smartsimple.ca
Program Description
Tipsheet for applicants





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive